Contrastingly, TERF2IP expression has previously been reported to be significantly higher in breast tumour tissues relative to adjacent non-tumour tissues [71], and highly expressed in colorectal cancer tissues; with high expression correlated with poor prognosis and distant metastasis in colorectal cancer [72]. This evidence concerns the gene TERF2IP and neoplasm.